日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study

更正：真实世界中一线血管内皮生长因子靶向治疗后转移性肾细胞癌患者的序贯治疗：流行病学、非干预性、回顾-前瞻性队列多中心研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06161-6
Cesas, Alvydas; Urbonas, Vincas; Tulyte, Skaiste; Janciauskiene, Rasa; Liutkauskiene, Sigita; Grabauskyte, Ingrida; Gaidamavicius, Ignas
肿瘤
肿瘤免疫
肾癌
心血管
细胞生物学
发表日期：2025
文献求助 收藏

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Gastric Cancer Peritoneal Metastases: Results from the Lithuanian PIPAC Program

加压腹腔内气溶胶化疗（PIPAC）治疗胃癌腹膜转移：立陶宛PIPAC项目的结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16172992
Luksta, Martynas; Bausys, Augustinas; Gendvilaite, Neda; Bickaite, Klaudija; Rackauskas, Rokas; Paskonis, Marius; Luksaite-Lukste, Raminta; Ranceva, Anastasija; Stulpinas, Rokas; Brasiuniene, Birute; Baltruskeviciene, Edita; Lachej, Nadezda; Bausiene, Juste; Poskus, Tomas; Bausys, Rimantas; Tulyte, Skaiste; Strupas, Kestutis
胃癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study

顺铂和多柔比星联合FOLFOX化疗方案，作为一线治疗胃癌腹膜转移患者的加压腹腔内气溶胶化疗（PIPAC）：单臂II期研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11549-z
Luksta, Martynas; Bausys, Augustinas; Bickaite, Klaudija; Rackauskas, Rokas; Paskonis, Marius; Luksaite-Lukste, Raminta; Ranceva, Anastasija; Stulpinas, Rokas; Brasiuniene, Birute; Baltruskeviciene, Edita; Lachej, Nadezda; Sabaliauskaite, Rasa; Bausys, Rimantas; Tulyte, Skaiste; Strupas, Kestutis
胃癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study

在真实世界环境下，对接受一线血管内皮生长因子靶向治疗的转移性肾细胞癌患者进行序贯治疗：一项流行病学、非干预性、回顾-前瞻性队列多中心研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-04645-x
Cesas, Alvydas; Urbonas, Vincas; Tulyte, Skaiste; Janciauskiene, Rasa; Liutkauskiene, Sigita; Grabauskyte, Ingrida; Gaidamavicius, Ignas
肿瘤
肿瘤免疫
肾癌
心血管
细胞生物学
发表日期：2023
文献求助 收藏

A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)

对达拉非尼和/或达拉非尼联合曲美替尼治疗转移性黑色素瘤患者的回顾性分析，旨在描述个体患者计划中长期获益的患者（DESCRIBE III）

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13102466
Atkinson, Victoria G; Quaglino, Pietro; Aglietta, Massimo; Del Vecchio, Michele; Depenni, Roberta; Consoli, Francesca; Bafaloukos, Dimitrios; Ferrucci, Pier Francesco; Tulyte, Skaiste; Krajsová, Ivana; Ascierto, Paolo A; Gueli, Rossana; Arance, Ana; Gogas, Helen; Banerjee, Hiya; Saliba, Teddy; de Jong, Egbert; Neyns, Bart
SCRIB
黑色素瘤
发表日期：2021
文献求助 收藏